900 Walnut Street
Suite 200
Philadelphia, PA 19107
(215) 955-7000
(215) 503-9170 fax
Suite 200
Philadelphia, PA 19107
(215) 955-7000
(215) 503-9170 fax
Most Recent Peer-reviewed Publications
- Replacing a dopamine agonist by the COMT-inhibitor tolcapone as an adjunct to l-dopa in the treatment of Parkinson's disease: A randomized, multicenter, open-label, parallel-group study
- Entacapone to tolcapone switch: Multicenter double-blind, randomized, active-controlled trial in advanced Parkinson's disease
- The Parkinson-control study: A 1-year randomize, double-blind trial comapring piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease
- High Dose Treatment of Parkinson's Disease with α-Dihydroergocryptine | Hochdosistherapie des Morbus Parkinson mit α-Dihydroergocryptin
- Budipine provides additional benefit in patients with Parkinson disease receiving a stable optimum dopaminergic drug regimen
Medical School
SUNY Health Sciences Center at Brooklyn - 1986
Residency
Boston University Medical Center Hospital
Fellowship
Massachusetts General Hospital, Boston, MA
Board Certification
Neurology
Hospital Appointment
Thomas Jefferson University Hospital
Methodist Hospital Division of Thomas Jefferson University Hospital